Regional, provider, and economic factors associated with the choice of active surveillance in the treatment of men with localized prostate cancer.

@article{Hamilton2012RegionalPA,
  title={Regional, provider, and economic factors associated with the choice of active surveillance in the treatment of men with localized prostate cancer.},
  author={Ann S. Hamilton and Xiaocheng Wu and Joseph Lipscomb and Steven T. Fleming and Mary J Lo and Dian Wang and Michael Wayne Goodman and Alex Ho and Jean B. Owen and Chandrika Rao and Robert R German},
  journal={Journal of the National Cancer Institute. Monographs},
  year={2012},
  volume={2012 45},
  pages={213-20}
}
Data on initial treatment of 8232 cases of localized prostate cancer diagnosed in 2004 were obtained by medical record abstraction (including hospital and outpatient locations) from seven state cancer registries participating in the Centers for Disease Control and Prevention's Breast and Prostate Cancer Data Quality and Patterns of Care Study. Distinction… CONTINUE READING